Immune globulin subcutaneous, human – klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study

Immunotherapy, Ahead of Print.

Source: Immunotherapy - October 16, 2019 Category: Allergy & Immunology Authors: John W Sleasman William R Lumry Iftikhar Hussain H James Wedner James B Harris Kecia L Courtney Elsa Mondou Jiang Lin Mark R Stein Source Type: research